Company intelligence / Profile preview

Skinfix

Halifax, Nova Scotia, Canada

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Skinfix’s clinically tested and dermatologist-recommended topical barrier therapies, including its patented Triple Lipid Complex™ line, show rapid and significant improvement in skin barrier strength and hydration in both clinical and consumer studies. The company’s Barrier+ line improved skin barrier function by 95% in one hour in clinical settings[1][3].

Therapeutic areas: Dermatology
Modalities: Topical therapyBiologic-inspired therapySmall moleculePeptides
Industry: Biotech

Partnerships

Stride Consumer Partners (investor)Dermatology officesRetail partner: Sephora

Beyond the preview

Go deeper on Skinfix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skinfix.

Explore the full profile